Dong Ju Kim, Dong Geun Kim, Hyun Duck Kwak, Jae Yong Jang, Yong-Sok Ji, Seung Hyun Lee, Eun Kyoung Lee, Kyu Hyung Park, Jae Hui Kim, Jun Sung Lee, Yumi Song, Seong Taeck Kim, Min Ho Shin, Min Kim, Sang Jun Park, Kwangsic Joo, Min Sagong, Christopher Seungkyu Lee, Se Joon Woo
PURPOSE: To investigate the long-term efficacy and safety of intravitreal brolucizumab (BRZ) injections in patients with typical neovascular age-related macular degeneration (typical nAMD) and polypoidal choroidal vasculopathy (PCV). METHODS: This multicentre retrospective study included 401 eyes of 398 patients with nAMD who received BRZ injection(s), with a follow-up duration of ≥12 months. Changes in best-corrected visual acuity (BCVA), retinal fluid evaluation and central subfield thickness (CST) on optical coherence tomography were assessed...
May 5, 2024: Acta Ophthalmologica